Acura Pharmaceuticals Inc (ACUR.OQ)
ACUR.OQ on NASDAQ Stock Exchange Capital Market
2.01USD
1 Aug 2013
2.01USD
1 Aug 2013
Price Change (% chg)
$-0.03 (-1.47%)
$-0.03 (-1.47%)
Prev Close
$2.04
$2.04
Open
$1.99
$1.99
Day's High
$2.01
$2.01
Day's Low
$1.95
$1.95
Volume
17,923
17,923
Avg. Vol
92,919
92,919
52-wk High
$4.49
$4.49
52-wk Low
$1.06
$1.06
About
Acura Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, utilizing its Aversion and Impede Technologies. Aversion is a mixture of inactive ingredients incorporated into pharmaceutical tablets and... (more)
Overall
| Beta: | 0.80 |
| Market Cap (Mil.): | $94.61 |
| Shares Outstanding (Mil.): | 46.38 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ACUR.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.24 | -- | -- |
| ROI: | -40.70 | -2.58 | 18.76 |
| ROE: | -40.70 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Pain Therapeutics, Inc. (PTIE.OQ) | $2.46 | +0.04 |
| Pfizer Inc. (PFE.N) | $29.29 | +0.06 |
| Grifols SA (GRLS.MC) | €32.62 | +0.92 |
| Grifols SA (GRLSbn.MC) | €24.52 | +0.43 |
| Onyx Pharmaceuticals, Inc. (ONXX.OQ) | $132.95 | +1.65 |
| AstraZeneca plc (AZN.L) | 3,322.50p | -12.50 |
| Bayer AG (BAYGn.DE) | €89.67 | +2.32 |
| Bayer AG (BAYE.F) | -- | -- |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

